Anti-BCMA CAR T-celtherapie bij RRMM

Delen via:
ASH Annual Meeting 2017

Log hier in om volledige toegang te krijgen.

Login of Account maken

 

Bronnen:
Berdeja JG, Lin Y, Raje N, et al. Durable Clinical Responses in Heavily Pretreated Patients with Relapsed/Refractory Multiple Myeloma: Updated Results from a Multicenter Study of bb2121 Anti-Bcma CAR T Cell Therapy. ASH 59th Annual Meeting & Exhibition, abstract 740.